List of Valeant Pharmaceuticals patents

Patents where

Current Assignee

Name

Valeant Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8067452 3-hydroxyisothiazole-4-carboxamidine derivatives as CHK2 inhibitors	Patent 8067452 was granted and assigned to Valeant Pharmaceuticals on November, 2011 by the United States Patent and Trademark Office.		Valeant Pharmaceuticals	United States Patent and Trademark Office	8067452	November 29, 2011
‌ US Patent 7217815 2-beta -modified-6-substituted adenosine analogs and their use as antiviral agents	Patent 7217815 was granted and assigned to Valeant Pharmaceuticals on May, 2007 by the United States Patent and Trademark Office.		Valeant Pharmaceuticals	United States Patent and Trademark Office	7217815	May 15, 2007
‌ US Patent 10251895 Topical compositions and methods for treating psoriasis	Patent 10251895 was granted and assigned to Valeant Pharmaceuticals on April, 2019 by the United States Patent and Trademark Office.	Valeant Pharmaceuticals	Valeant Pharmaceuticals	United States Patent and Trademark Office	10251895	April 9, 2019
‌ US Patent 8993593 N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators	Patent 8993593 was granted and assigned to Valeant Pharmaceuticals on March, 2015 by the United States Patent and Trademark Office.		Valeant Pharmaceuticals	United States Patent and Trademark Office	8993593	March 31, 2015
‌ US Patent 7786146 Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators	Patent 7786146 was granted and assigned to Valeant Pharmaceuticals on August, 2010 by the United States Patent and Trademark Office.		Valeant Pharmaceuticals	United States Patent and Trademark Office	7786146	August 31, 2010
‌ US Patent 8859618 Silicone gel-based compositions for wound healing and scar reduction	Patent 8859618 was granted and assigned to Valeant Pharmaceuticals on October, 2014 by the United States Patent and Trademark Office.	Valeant Pharmaceuticals	Valeant Pharmaceuticals	United States Patent and Trademark Office	8859618	October 14, 2014
‌ US Patent 8188314 Benzyloxy anilide derivatives useful as potassium channel modulators	Patent 8188314 was granted and assigned to Valeant Pharmaceuticals on May, 2012 by the United States Patent and Trademark Office.		Valeant Pharmaceuticals	United States Patent and Trademark Office	8188314	May 29, 2012
‌ US Patent 7799908 Synthesis and use of 2′-substituted-N	Patent 7799908 was granted and assigned to Valeant Pharmaceuticals on September, 2010 by the United States Patent and Trademark Office.		Valeant Pharmaceuticals	United States Patent and Trademark Office	7799908	September 21, 2010
‌ US Patent 7638496 Nucleoside analogs with carboxamidine modified monocyclic base	Patent 7638496 was granted and assigned to Valeant Pharmaceuticals on December, 2009 by the United States Patent and Trademark Office.		Valeant Pharmaceuticals	United States Patent and Trademark Office	7638496	December 29, 2009
‌ US Patent 8722929 N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators	Patent 8722929 was granted and assigned to Valeant Pharmaceuticals on May, 2014 by the United States Patent and Trademark Office.		Valeant Pharmaceuticals	United States Patent and Trademark Office	8722929	May 13, 2014
‌ US Patent 7799832 Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains	Patent 7799832 was granted and assigned to Valeant Pharmaceuticals on September, 2010 by the United States Patent and Trademark Office.		Valeant Pharmaceuticals	United States Patent and Trademark Office	7799832	September 21, 2010
‌ US Patent 8338487 Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and -2,3-dihydro-	Patent 8338487 was granted and assigned to Valeant Pharmaceuticals on December, 2012 by the United States Patent and Trademark Office.		Valeant Pharmaceuticals	United States Patent and Trademark Office	8338487	December 25, 2012
‌ US Patent 8563604 Silicone gel-based compositions for wound healing and scar reduction			Valeant Pharmaceuticals	United States Patent and Trademark Office	8563604	October 22, 2013
‌ US Patent 8030518 1,4 diamino bicyclic retigabine analogues as potassium channel modulators	Patent 8030518 was granted and assigned to Valeant Pharmaceuticals on October, 2011 by the United States Patent and Trademark Office.		Valeant Pharmaceuticals	United States Patent and Trademark Office	8030518	October 4, 2011
‌ US Patent 8367684 Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators	Patent 8367684 was granted and assigned to Valeant Pharmaceuticals on February, 2013 by the United States Patent and Trademark Office.		Valeant Pharmaceuticals	United States Patent and Trademark Office	8367684	February 5, 2013
‌ US Patent 8492588 Benzyloxy anilide derivatives useful as potassium channel modulators	Patent 8492588 was granted and assigned to Valeant Pharmaceuticals on July, 2013 by the United States Patent and Trademark Office.		Valeant Pharmaceuticals	United States Patent and Trademark Office	8492588	July 23, 2013
‌ US Patent 8211918 Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators	Patent 8211918 was granted and assigned to Valeant Pharmaceuticals on July, 2012 by the United States Patent and Trademark Office.		Valeant Pharmaceuticals	United States Patent and Trademark Office	8211918	July 3, 2012
‌ US Patent 8293911 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators	Patent 8293911 was granted and assigned to Valeant Pharmaceuticals on October, 2012 by the United States Patent and Trademark Office.		Valeant Pharmaceuticals	United States Patent and Trademark Office	8293911	October 23, 2012
‌ US Patent 7960436 Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-	Patent 7960436 was granted and assigned to Valeant Pharmaceuticals on June, 2011 by the United States Patent and Trademark Office.		Valeant Pharmaceuticals	United States Patent and Trademark Office	7960436	June 14, 2011
‌ US Patent 8575331 Synthesis and use of 2′-substituted-N6-modified nucleosides			Valeant Pharmaceuticals	United States Patent and Trademark Office	8575331	November 5, 2013
‌ US Patent 8563566 Naphthyridine derivatives as potassium channel modulators			Valeant Pharmaceuticals	United States Patent and Trademark Office	8563566	October 22, 2013

21 results

0 selected

21 results

0 selected